Regulatory Approval Delays or Failures: The complex and stringent regulatory approval process (e.g., FDA, CE Mark) poses a significant risk. Delays in obtaining or failures to obtain necessary approvals for CapsoVision's devices could prevent market entry or expansion, leading to substantial financial losses and impacting product commercialization timelines.

Intense Market Competition: CapsoVision operates in a highly competitive medical device market, particularly within capsule endoscopy, where established players hold significant market share. Failure to differentiate its products effectively, innovate rapidly, or compete on price and features could limit market penetration and revenue growth.

Limited Market Adoption and Reimbursement Challenges: Even with regulatory approval, securing broad market adoption by healthcare providers and favorable reimbursement from insurance payers is crucial. Lack of physician acceptance due to integration complexities, or inadequate reimbursement coverage, could severely restrict sales volumes and profitability.